This event is sponsored by California Life Sciences (CLSA) and hosted by Charles River Laboratories
There is currently an abundance of early-stage biotech companies opening their doors in and around California. While the promise of a start-up is significant, so are the risks and uncertainties of product development, and there are a few key elements that are critical to its growth and success. Those components are expertise in scientific research, leadership in business, and at least one great idea for a product.
Gain insight from industry leaders on how to advance product candidates with dependence on a combination of corporate alliances, financing strategy, and strategic planning. Success in each stage of the life cycle requires thorough and methodical consideration. Our experts will provide guidance on how to overcome common challenges from early-stage development to market.
Desmond Padhi, BSc, PharmD
Principal, Westlake Village BioPartners
Jeffrey R Jasper, PhD
Vice President, Drug Discovery – Rubedo Life Sciences, Inc.
Irene Griswold-Prenner, PhD
CEO & CSO – Nitrome Biosciences
Omar Aziz, PhD (Moderator)
General Manager South San Francisco, Discovery Services – Charles River